Jacobus Pfisterer
Städtisches Klinikum Solingen, Clinical Research Center Kiel
Papers
2
Total Citations
89
H-Index
2
About
Jacobus Pfisterer is a leading figure in gynecologic oncology, renowned for his pivotal research on borderline ovarian tumors (BOTs). His work has fundamentally advanced the understanding of how patient age influences the clinical behavior and prognosis of these complex neoplasms. In his landmark study, the sub-analysis of the AGO ROBOT study, Pfisterer demonstrated that younger women with BOTs exhibit distinct clinical characteristics and significantly better outcomes compared to older patients, a finding cited over 75 times for its critical impact on personalized treatment strategies. He further contributed to refining diagnostic accuracy by evaluating the utility of serum CA125 levels specifically for borderline tumors, providing essential guidance for clinicians. Pfisterer’s contributions have shaped modern management protocols, emphasizing the need for age-specific risk assessment and conservative surgery. His work remains a cornerstone for researchers and clinicians navigating the nuances of ovarian malignancies, solidifying his legacy as a key architect in the field of gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary14 citations · 2015